MEDICAL RESEARCH
Untitled Page
Cortex's drug therapy ...
“Professor Lynch’s studies in mice support the rationale for Cortex to develop AMPAKINE molecules to address the memory deficits in patients suffering from Huntington’s disease," asserts Mark Varney, president and CEO of Cortex.
The studies were published in the online version of Proceedings of the National Academy of Sciences journal.
Cortex Pharmaceuticals is a neuroscience company developing drug therapies for treating psychiatric and brain-related breathing disorders, and neurological diseases.
PAGE ONE
Related headlines
Irvine-based Masimo's product revenue jumps 30 percent in 2008
St. Joseph's Hospital of Orange gets blue light
UC Irvine researchers study brain link to autism
"OC METRO Minute," March 5: Tissue engineering, regenerative medicine markets expected to grow by 2013
Cortex's drug therapy ...
“Professor Lynch’s studies in mice support the rationale for Cortex to develop AMPAKINE molecules to address the memory deficits in patients suffering from Huntington’s disease," asserts Mark Varney, president and CEO of Cortex.The studies were published in the online version of Proceedings of the National Academy of Sciences journal.
Cortex Pharmaceuticals is a neuroscience company developing drug therapies for treating psychiatric and brain-related breathing disorders, and neurological diseases.
PAGE ONE
Related headlines
Irvine-based Masimo's product revenue jumps 30 percent in 2008
St. Joseph's Hospital of Orange gets blue light
UC Irvine researchers study brain link to autism
"OC METRO Minute," March 5: Tissue engineering, regenerative medicine markets expected to grow by 2013
